Navigation Links
TNFerade in Medical News

GenVec Announces Second Quarter 2009 Results Conference Call

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...

GenVec Receives Grant for Malaria Vaccine Program

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...
TNFerade in Medical Technology

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

GAITHERSBURG, Md.--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc. (Nasdaq: GNVC) announced today that updated preliminary safety and efficacy data from the clinical development program of its lead product TNFerade(TM) was presented in a poster session on gastrointestinal cancers at the annual meeting ...

TNFerade(TM) Phase III Data Presented at ASCO

...ts) had occurred. The analysis concluded that tnferade appeared to be safe and well-tolerated. The analys...icated a 25% reduction in the risk of death in the tnferade plus standard-of-care (SOC) arm compared to the pa... within approximately 11.8 months. However, in the tnferade plus SOC group, 75% of the patients did not die un...

GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy

...e) is an adenovector, or DNA carrier, which contains the gene for TNF(alpha), a potent immune system protein with well-documented anti-cancer effects. tnferade is currently in a pivotal Phase II/III trial for locally advanced pancreatic cancer. GenVec researchers presented a poster entitled, "Selective deliv...
TNFerade in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

...by increases related to the manufacturing costs of tnferade arising from the letter agreement and subsequent t... Second Quarter and Recent Highlights tnferade for Cancer As of July 31, 2009, 262 ...tudy (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for...

GenVec Expands Contract Supporting Malaria Vaccine Program

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...
Other Tags
(Date:4/24/2014)... TORONTO Baker,s yeast is giving scientists a better ... of hospitalization and illness world-wide. , When two ... one can suppress or enhance the effectiveness of the ... of another. These types of interactions are a major ... severe practical limits on the practical scope of drug ...
(Date:4/24/2014)... lenses coated with an antimicrobial peptide could help to lower ... Optometry and Vision Science , official journal ... journal is published by Lippincott Williams & Wilkins , ... in animals and now humans support the biocompatibility and safety ... the new research by Debarun Dutta, B.Optom, of The University ...
(Date:4/24/2014)... Center for BrainHealth will bring together national experts ... challenges at its inaugural Brain Health Summit, titled ... speakers will include Dr. Sandra Bond Chapman, founder ... U.S. Senator Chuck Grassley (R-IA), U.S. Representative Chaka ... for Policy and Early Learning, U.S. Department of ...
(Date:4/24/2014)... the corresponding terminology, and the relevance of palliation ... publications on randomized controlled trials (RCTs). This is ... Institute for Quality and Efficiency in Health Care ... report. , Together with external experts, IQWiG analysed ... lung cancer, malignant melanoma, and pancreatic cancer. For ...
(Date:4/24/2014)... than to receive at least if you,re an adolescent ... study found that 15- and 16-year-olds who find pleasure in ... are less likely to become depressed than those who get ... for themselves. , The researchers detail their findings in the ... The study focused on the ventral striatum, a brain region ...
Breaking Medicine News(10 mins):Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Study: Altruistic adolescents less likely to become depressed 2
(Date:4/24/2014)... play a crucial role in the global-scale cycling ... atmosphere. Now scientists at Scripps Institution of Oceanography ... forward in understanding the microscopic underpinnings of these ... make new cells, a substantial portion of that ... a buffet of edible molecules collectively called "dissolved ...
(Date:4/24/2014)... WEST LAFAYETTE, Ind. - Purdue and West Virginia University ... the golden eagle, providing a bird,s-eye view of eagle ... , Their study calls into question long-held assumptions ... not be as sensitive to ultraviolet light as previously ... have a sharper sense of smell than researchers realized. ...
(Date:4/24/2014)... a commercially important sugar used as a sweetener, ... for synthesizing riboflavin and several antiviral drugs. Genetic ... the bacteria,s ability to produce D-ribose is a ... of this valuable chemical, as described in an ... journal from Mary Ann Liebert, Inc., publishers. The ...
Breaking Biology News(10 mins):Microscopic organism plays a big role in ocean carbon cycling, Scripps scientists discover 2Microscopic organism plays a big role in ocean carbon cycling, Scripps scientists discover 3Genome yields insights into golden eagle vision, smell 2
Other Contents